NCT00520754View on ClinicalTrials.gov

Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Cough
Interventions
DRUG

levocetirizine dihydrochloride

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00520754 - Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children | Biotech Hunter | Biotech Hunter